GAMMA;-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory Microenvironment (Expression of Concern of Vol 70, Pg 8695, 2010)

被引：0
|
作者：
不详
机构：
来源：
CANCER RESEARCH | 2018年 / 78卷 / 17期
关键词：
D O I：
10.1158/0008-5472.CAN-18-1826
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5181 / 5181
页数：1
相关论文
共 4 条
  • [1] γ-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory Microenvironment (Publication with Expression of Concern. See vol. 78, pg. 5181, 2018)
    Kunnumakkara, Ajaikumar B.
    Sung, Bokyung
    Ravindran, Jayaraj
    Diagaradjane, Parmeswaran
    Deorukhkar, Amit
    Dey, Sanjit
    Koca, Cemile
    Yadav, Vivek R.
    Tong, Zhimin
    Gelovani, Juri G.
    Guha, Sushovan
    Krishnan, Sunil
    Aggarwal, Bharat B.
    [J]. CANCER RESEARCH, 2010, 70 (21) : 8695 - 8705
  • [2] Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatoxicity (Expression of Concern of Vol 16, Pg 479, 2010)
    Antoine, Daniel James
    Williams, Dominic P.
    Kipar, Anja
    Laverty, Hugh
    Park, B. Kevin
    [J]. MOLECULAR MEDICINE, 2020, 26 (01)
  • [3] Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment (vol 12, pg 615, 2010)
    Kidd, Shannon
    Caldwell, Lisa
    Dietrich, Martin
    Samudio, Ismael
    Spaeth, Erika L.
    Watson, Keri
    Shi, Yuexi
    Abbruzzese, James
    Konopleva, Marina
    Andreeff, Michael
    Marini, Frank C.
    [J]. CYTOTHERAPY, 2011, 13 (04) : 498 - 498
  • [4] RETRACTION: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retraction of Vol 70, Pg 3606, 2010)
    Philip, P. A.
    Ahmad, A.
    Banerjee, S.
    Wang, Z.
    Sarkar, F. H.
    Ali, S.
    Padhye, S.
    Dominiak, K.
    Schaffert, J. M.
    [J]. CANCER RESEARCH, 2018, 78 (18) : 5466 - 5466
1